AZTA vs FROG vs BLFS

For growth investors, JFrog Ltd.

(FROG) is the stronger pick with 24. 1% revenue growth year-over-year, versus 3. 6% for Azenta, Inc. (AZTA). Analysts rate Azenta, Inc. (AZTA) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, JFrog Ltd.

(FROG) delivered a total return of +58. 8%, compared to -81. 0% for Azenta, Inc. (AZTA). Over 10 years, the gap is even starker: BLFS returned +1221% versus FROG's -12. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), JFrog Ltd.

(FROG) is the lower-risk stock at 1. 24β versus Azenta, Inc. 's 2. 17β — meaning AZTA is approximately 76% more volatile than FROG relative to the S&P 500. On balance sheet safety, JFrog Ltd. (FROG) carries a lower debt/equity ratio of 2% versus 6% for Azenta, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), JFrog Ltd.

(FROG) is pulling ahead at 24. 1% versus 3. 6% for Azenta, Inc. (AZTA). On earnings-per-share growth, the picture is similar: Azenta, Inc. grew EPS 60. 5% year-over-year, compared to 1. 6% for JFrog Ltd.. Over a 3-year CAGR, FROG leads at 23. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Azenta, Inc.

(AZTA) is the more profitable company, earning -9. 4% net margin versus -13. 5% for JFrog Ltd. — meaning it keeps -9. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AZTA leads at -1. 9% versus -15. 7% for FROG. At the gross margin level — before operating expenses — FROG leads at 76. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Azenta, Inc.

(AZTA) trades at 23. 7x forward P/E versus 156. 4x for BioLife Solutions, Inc. — 132. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AZTA: 140. 5% to $44. 67.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, BioLife Solutions, Inc.

(BLFS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1221% 10Y return). Azenta, Inc. (AZTA) carries a higher beta of 2. 17 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BLFS: +1221%, AZTA: +123. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AZTA (Healthcare) and FROG (Technology) and BLFS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AZTA is a small-cap quality compounder stock; FROG is a small-cap high-growth stock; BLFS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.